Dermatology
Onychomycosis
0
Pipeline Programs↗
5
Active Trials↗
19
Companies Involved↗
Onychomycosis is an early-stage landscape with 0 programs across 19 companies. The most active players are Pfizer, Celtic Pharma Development Services, Nitric BioTherapeutics, Inc.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
49
clinical trials
Completed31 · 63%
Unknown status11 · 22%
Active, not recruiting3 · 6%
Terminated2 · 4%
Not yet recruiting2 · 4%
Clinical Trials
Trial Activity
49 trials
Exploring Different Dose-frequency Home Photodynamic Therapy Protocols Using a Novel Home-targeted LED Device for Onychomycosis
Active, not recruiting·—·N/A·NCT07012343·50 enrolled
A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails
Not yet recruiting·—·Phase 2·NCT07382427·200 enrolled
Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis
Completed·—·Phase 1·NCT05578950·100 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)